Expt | Vaccine | Dosage | Neutralizing antibody titera | Survival rate (no. alive/total) | |
---|---|---|---|---|---|
 |  |  | Day 14 | Day 28 |  |
1 | BJ-MEb (oil adjuvant) | 2 μg | 40 | 100 | 100% (10/10) |
 | BJ-ME (no adjuvant) | 2 μg | 70 | 100 | 100% (10/10) |
 | BJ-ME (no adjuvant) | 4 μg | 100 | 280 | 100% (10/10) |
 | Live vacc | 106 TCID50 | 100 | 120 | 100% (10/10) |
 | PBS | 200 μL | <10 | <10 | 0% (0/10) |
2 | BJ-ME 200 μl | 3 μg | ND | 160 | 100% (8/8) |
 | BJ-ME 150 μl | 2.25 μg | ND | 140 | 100% (8/8) |
 | BJ-ME 100 μl | 1.5 μg | ND | 100 | 87.5% (7/8) |
 | BJ-ME 50 μl | 0.75 μg | ND | 70 | 87.5% (7/8) |
 | BJ-ME 20 μl | 0.3 μg | ND | 40 | 75% (6/8) |
 | Live vac | 106 TCID50 | ND | 160 | 100% (8/8) |
 | PBS | 200 μL | ND | <10 | 0% (0/8) |